SCHEMBL1509564

SCHEMBL1509564

O=C(O)Oc1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7262842 0.81
SCHEMBL5160015 0.81
SCHEMBL6602546 0.81
Hydrochloric Acid SCHEMBL9623702 0.79 SLC22A6 (0.33)
SCHEMBL27502205 0.79 PDE5A (0.33)
SCHEMBL2143933 0.78 KDM4E (0.33)
SCHEMBL27498398 0.77 KMT2A (0.44)
SCHEMBL2154513 0.76 HIF1A (0.37)
SCHEMBL6237082 0.76 THRB (0.34)
SCHEMBL27766901 0.76 ELANE (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3256102-B1 PEPTIDIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES OF SAID COMPOUNDS, IN PARTICULAR COSMETIC USES SEDERMA SA (FR) 2023-08-09 EP claimed
EP-1900393-B1 Hydrogen peroxide activation with diones and imidazoles HENKEL AG & CO KGAA (DE) 2018-02-28 EP claimed
EP-2192957-A1 BRIGHTENING AGENT COMPRISING CATIONIC 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND HYDROGEN PEROXIDE Henkel AG & Co. KGaA (DE) 2010-06-09 EP claimed
EP-2149551-A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP claimed
EP-2051689-A1 LIGHTENING AGENTS AND/OR DYES THAT CONTAIN ALDEHYDE(S) Henkel AG & Co. KGaA (DE) 2009-04-29 EP claimed
WO-2009043613-A1 BRIGHTENING AGENT COMPRISING CATIONIC 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND HYDROGEN PEROXIDE HENKEL AG & CO. KGAA (DE) 2009-04-09 WO claimed
EP-2007344-A1 BLEACHING AND/OR COLOURING AGENT WITH IMPROVED SKIN COMPATIBILITY Henkel AG & Co. KGaA (DE) 2008-12-31 EP claimed
EP-2002834-A1 Aryl and hetaryl amides as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP claimed
EP-1905418-A2 Hydrogen peroxide activation with N-heterocycles Henkel Kommanditgesellschaft auf Aktien (DE) 2008-04-02 EP claimed
EP-1900355-A2 Bleaching and/or dyeing agent with heterocyclic aldehydes Henkel Kommanditgesellschaft auf Aktien (DE) 2008-03-19 EP claimed
WO-2007121853-A2 LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES HENKEL AG & CO. KGAA (DE) 2007-11-01 WO claimed
WO-2007121851-A1 LIGHTENING AND/OR COLOURING AGENTS COMPRISING HALOGENATED KETONES HENKEL AG & CO. KGAA (DE) 2007-11-01 WO claimed
WO-2007121852-A2 LIGHTENING AND/OR COLOURING AGENTS COMPRISING AMIDINES HENKEL AG & CO. KGAA (DE) 2007-11-01 WO claimed
WO-2007118616-A1 BLEACHING AND/OR COLOURING AGENT WITH IMPROVED SKIN COMPATIBILITY HENKEL AG & CO. KGAA (DE) 2007-10-25 WO claimed
WO-2007096027-A1 BLEACHING AGENTS HENKEL AG & CO. KGAA (DE) 2007-08-30 WO claimed
EP-1781620-A1 NOVEL BETA AGONISTS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-09 EP claimed
EP-1196129-B1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING UROCANIC ACID DERIVATIVES AS RADICAL SCAVENGERS OR ANTIOXIDANTS AZ UNIV AMSTERDAM (NL) 2005-12-07 EP claimed
WO-2005108373-A1 NOVEL BETA AGONISTS, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-17 WO claimed
EP-1529247-A1 USE OF SALTS OF LAYERED DOUBLE HYDROXIDES Clariant GmbH (DE) 2005-05-11 EP claimed
WO-2004019138-A1 USE OF SALTS OF LAYERED DOUBLE HYDROXIDES CLARIANT GMBH (DE) 2004-03-04 WO claimed